ATE261442T1 - Imidazolderivate, ihrer herstellung, zwischenprodukte, und ihre verwendung als arzneimittel - Google Patents

Imidazolderivate, ihrer herstellung, zwischenprodukte, und ihre verwendung als arzneimittel

Info

Publication number
ATE261442T1
ATE261442T1 AT95927003T AT95927003T ATE261442T1 AT E261442 T1 ATE261442 T1 AT E261442T1 AT 95927003 T AT95927003 T AT 95927003T AT 95927003 T AT95927003 T AT 95927003T AT E261442 T1 ATE261442 T1 AT E261442T1
Authority
AT
Austria
Prior art keywords
products
pct
aryl
production
imidazole derivatives
Prior art date
Application number
AT95927003T
Other languages
English (en)
Inventor
Bertrand Heckmann
Jean-Paul Vevert
Jidong Zhang
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of ATE261442T1 publication Critical patent/ATE261442T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT95927003T 1994-08-02 1995-08-01 Imidazolderivate, ihrer herstellung, zwischenprodukte, und ihre verwendung als arzneimittel ATE261442T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9409565A FR2723369B1 (fr) 1994-08-02 1994-08-02 Nouveaux derives de l'imidazole, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
PCT/FR1995/001033 WO1996004275A1 (fr) 1994-08-02 1995-08-01 Nouveaux derives de l'imidazole, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant

Publications (1)

Publication Number Publication Date
ATE261442T1 true ATE261442T1 (de) 2004-03-15

Family

ID=9465985

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95927003T ATE261442T1 (de) 1994-08-02 1995-08-01 Imidazolderivate, ihrer herstellung, zwischenprodukte, und ihre verwendung als arzneimittel

Country Status (18)

Country Link
US (1) US5856509A (de)
EP (1) EP0804435B1 (de)
JP (1) JP3950475B2 (de)
CN (1) CN1083838C (de)
AT (1) ATE261442T1 (de)
AU (1) AU703078B2 (de)
BR (1) BR9508482A (de)
CA (1) CA2196219A1 (de)
DE (1) DE69532684T2 (de)
ES (1) ES2214504T3 (de)
FI (1) FI970423L (de)
FR (1) FR2723369B1 (de)
HU (1) HU221463B (de)
IL (1) IL114663A0 (de)
MX (1) MX9700820A (de)
RU (1) RU2171257C2 (de)
WO (1) WO1996004275A1 (de)
ZA (1) ZA956450B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2740774B1 (fr) * 1995-11-08 1997-12-19 Roussel Uclaf Nouveaux derives d'imidazole n-benzyldioxole, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation
EP0990439A4 (de) 1997-05-22 2004-01-28 Kyowa Hakko Kogyo Kk Bisarylverbindungen und diese enthaltende antikrebs-arzneimittel
SE0401653D0 (sv) * 2004-06-24 2004-06-24 Astrazeneca Ab New compounds
EP2095819A1 (de) * 2008-02-28 2009-09-02 Maastricht University N-Benzyl-Imidazolderivate und deren Verwendung als Aldosteronsynthaseinhibitoren

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0003732B1 (de) * 1978-02-01 1983-10-19 The Wellcome Foundation Limited Imidazolderivate und deren Salze, deren Herstellung sowie deren pharmazeutische Zusammensetzungen
JPH07509465A (ja) * 1992-07-17 1995-10-19 スミスクライン・ビーチャム・コーポレイション エンドセリン受容体アンタゴニスト

Also Published As

Publication number Publication date
AU3117895A (en) 1996-03-04
CN1083838C (zh) 2002-05-01
JPH10503512A (ja) 1998-03-31
US5856509A (en) 1999-01-05
AU703078B2 (en) 1999-03-11
ES2214504T3 (es) 2004-09-16
DE69532684D1 (de) 2004-04-22
CA2196219A1 (fr) 1996-02-15
EP0804435A1 (de) 1997-11-05
IL114663A0 (en) 1995-11-27
FR2723369B1 (fr) 1996-09-13
FR2723369A1 (fr) 1996-02-09
HUT76838A (en) 1997-11-28
FI970423A7 (fi) 1997-04-01
WO1996004275A1 (fr) 1996-02-15
EP0804435B1 (de) 2004-03-10
HU221463B (en) 2002-10-28
MX9700820A (es) 1997-05-31
ZA956450B (en) 1996-08-05
FI970423L (fi) 1997-04-01
RU2171257C2 (ru) 2001-07-27
FI970423A0 (fi) 1997-01-31
JP3950475B2 (ja) 2007-08-01
DE69532684T2 (de) 2004-07-29
BR9508482A (pt) 1999-06-01
CN1159805A (zh) 1997-09-17

Similar Documents

Publication Publication Date Title
AU2797695A (en) Thiazolidine derivatives, their preparation and drugs containing same
ATE148108T1 (de) Beta,beta-dimethyl-4-piperidinethanamin-derivat als inhibitoren der cholesterin-biosynthese
DK0728138T3 (da) Anthracyclinderivater
DE69532684D1 (de) Imidazolderivate, ihrer herstellung, zwischenprodukte, und ihre verwendung als arzneimittel
ATE108176T1 (de) Beta-phenylisoserinderivate, ihre herstellung und ihre anwendung.
IL108288A0 (en) Pyrrolidine derivatives, their preparation and medicaments containing them
DE69528902D1 (de) Neue verwendung und neue derivate von imidazol, ihrer herstellung, zwischenprodukte, und verwendung als arzneimittel
IL108290A0 (en) Pyrrolidine derivatives, their preparation and medicaments containing them
DE69512419D1 (de) IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZIN-2-CARBONSÄURE DERIVATE, IHRE HERSTELLUNG UND SIE ENTHALTENDE ARZNEIMITTEL
DE59507531D1 (de) Cyclohexanon-derivate, verfahren zu deren herstellung und zwischenprodukte des verfahrens
ATE195529T1 (de) 17beta-(2-oxo-tetrahydrofuran-4-yl)-thio- androstane derivate (17beta-(gamma-buttersäure- lacton)-thio derivate) zur behandlung von entzündungen, pharmazeutische präparate davon und ein verfahren zu ihrer herstellung
DK0623118T3 (da) Carbamatderivater og deres anvendelse i medicin
FI955142A0 (fi) Bentso(f)kinoksaliinidionijohdannaisia, niiden valmistus ja käyttö lääkkeinä
ZA955052B (en) Pyrrolidine derivatives their preparation and compositions containing them
DE69400908D1 (de) Verwendung von riluzol zum schutz gegen strahlenschäden

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties